/
CTSO
$0.39+$0.03 (+8.34%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$23.3M
63M shares
52-week range
$0.35 – $1.19
5% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-7.54
Cytosorbents Corp.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
www.cytosorbents.com- Employees
- 129
- IPO / List date
- May 17, 2005
- HQ
- PRINCETON, NJ
Held by traders on TradeandTell
No one on the platform currently holds CTSO.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 100,720 | $57.0K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2014-12-05 | 1-for-25reverse |
| 2006-06-28 | 1-for-5.8reverse |
Recent trades on TradeandTell
No one on the platform has traded CTSO yet.
